Details of the Drug

General Information of Drug (ID: DMHM8ZK)

• Drug Name: Propoxycaine
• Synonyms: Propoxycaine hydrochloride; Ravocaine hydrochloride; 550-83-4; Propoxycaine HCl; Propoxycaine (hydrochloride); Pravocaine hydrochloride; UNII-K490D39G46; WIN 3459; EINECS 208-988-7; Propoxycaine hydrochloride [USP]; K490D39G46; 2-(Diethylamino)ethyl 4-amino-2-propoxybenzoate monohydrochloride; 4-Amino-2-propoxybenzoic acid 2-(diethylamino)ethyl ester hydrochloride; Propoxycaine hydrochloride (USP); BENZOIC ACID, 4-AMINO-2-PROPOXY-, 2-(DIETHYLAMINO)ETHYL ESTER, MONOHYDROCHLORIDE; C16H26N2O3; NCGC00016505-01; CAS-550-83-4

Indication

Disease Entry	ICD 11	Status	REF
Pain	MG30-MG3Z	Approved	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C16H26N2O3
  Canonical SMILES: CCCOC1=C(C=CC(=C1)N)C(=O)OCCN(CC)CC
  InChI: InChI=1S/C16H26N2O3/c1-4-10-20-15-12-13(17)7-8-14(15)16(19)21-11-9-18(5-2)6-3/h7-8,12H,4-6,9-11,17H2,1-3H3
  InChIKey: CAJIGINSTLKQMM-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 6843
  ChEBI ID: CHEMBL1195
  CAS Number: 86-43-1
  UNII: EPD1EH7F53
  DrugBank ID: DB09342
  TTD ID: D0N6CR
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug Pharmacogenomic Perturbation (DPP)NEW: Click to Jump to the Detailed DPP Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015